Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Notch receptor 2 (NOTCH2) is a type I transmembrane protein and a member of the Notch family of receptors. It plays a critical role in cell fate determination during embryonic development and adult tissue homeostasis by mediating intercellular signaling. Upon ligand binding, NOTCH2 undergoes proteolytic cleavages, releasing the NICD which regulates gene expression. Dysregulation is implicated in diseases like Alagille syndrome, Hajdu–Cheney syndrome, and various cancers.
Ligand binding induces proteolytic cleavage, releasing the NICD which translocates to the nucleus and activates target genes through interaction with CSL and Mastermind-like proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Notch receptor 2 (NOTCH2).